Beneficio Operativo Cambio Fecha
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Assertio Holdings USD -3.05M 569K 2024-09
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 6.62B 1.03B 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pfizer USD 4.99B 340M 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03